- Home
- REZI vs NAMS Comparison
REZI vs NAMS Comparison
Compare REZI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REZI
- NAMS
- Stock Information
- Founded
- REZI 2018
- NAMS 2019
- Country
- REZI United States
- NAMS Netherlands
- Employees
- REZI N/A
- NAMS N/A
- Industry
- REZI Wholesale Distributors
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- REZI Industrials
- NAMS Health Care
- Exchange
- REZI Nasdaq
- NAMS Nasdaq
- Market Cap
- REZI 3.1B
- NAMS 2.5B
- IPO Year
- REZI N/A
- NAMS N/A
- Fundamental
- Price
- REZI $24.33
- NAMS $23.39
- Analyst Decision
- REZI Hold
- NAMS Strong Buy
- Analyst Count
- REZI 1
- NAMS 9
- Target Price
- REZI $21.00
- NAMS $41.11
- AVG Volume (30 Days)
- REZI 1.0M
- NAMS 858.2K
- Earning Date
- REZI 08-05-2025
- NAMS 08-06-2025
- Dividend Yield
- REZI N/A
- NAMS N/A
- EPS Growth
- REZI N/A
- NAMS N/A
- EPS
- REZI 0.30
- NAMS N/A
- Revenue
- REZI $7,045,000,000.00
- NAMS $47,140,000.00
- Revenue This Year
- REZI $11.43
- NAMS N/A
- Revenue Next Year
- REZI $3.45
- NAMS N/A
- P/E Ratio
- REZI $80.53
- NAMS N/A
- Revenue Growth
- REZI 14.02
- NAMS 586.97
- 52 Week Low
- REZI $14.18
- NAMS $14.06
- 52 Week High
- REZI $28.28
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- REZI 62.99
- NAMS 66.08
- Support Level
- REZI $23.91
- NAMS $22.00
- Resistance Level
- REZI $24.74
- NAMS $24.82
- Average True Range (ATR)
- REZI 0.58
- NAMS 1.18
- MACD
- REZI -0.03
- NAMS 0.27
- Stochastic Oscillator
- REZI 77.35
- NAMS 74.46
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.